Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study.
Igor P U CapitineIvalda B MacicameArtur M UanelaNilesh B BhattAdam YatesMark MilazzoChiaka NwogaTrevor A CrowellNelson L MichaelMerlin L RobbIlesh V JaniArne KroidlChristina S PolyakCaroline De Schachtnull nullPublished in: PloS one (2021)
The majority of our study population in Mozambique expressed willingness to participate in a theoretical HIV vaccine trial. Participation in a HIV vaccine trial was seen as a way to contribute to the fight against HIV but was associated with some unrealistic expectations such as protection against HIV. This reinforces the need for continuous mobilization and awareness of potential participants to HIV vaccine trial.